Aydın, GülşahKaya, Ertuğrul2024-12-282024-12-2820202717-7491https://dergipark.org.tr/tr/download/article-file/1115839https://dergipark.org.tr/tr/pub/ijtcmr/issue/56526/741493https://hdl.handle.net/20.500.12684/17151The use of herbs for therapeutic purposes has been widespread since ancient times. In traditional treatments, plants are applied in a variety of forms, either directly or prepared by isolation and / or enrichment of biologically active ingredients. Momordica charantia L. (bitter melon) is a popular bush that has traditional use as a supplement in the treatment of various diseases with its rich bioactive ingredient content. The plant has common pharmacological potential, including antimicrobial, antimutagenic, antifertility, antidiabetic, antioxidant, antilipolytic, hypoglycemic, anticancer, antimicrobial, antiviral and hepatoprotective activities. This review provides a short overview of the in vitro, in vivo and clinical studies conducted to evaluate the therapeutic efficacy and safety of Momordica charantia.trinfo:eu-repo/semantics/openAccessMomordica CharantiaBittermelonTraditional MedicineTraditional, Complementary and Integrative MedicineArticle127995DergiPark: 741493